alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp

Term ID

CHEBI:72467

Synonyms

3,5-dideoxy-5-(glycoloylamino)-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->4)beta--D-glucopyranose
alpha-N-glycoloylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucose
alpha-Neu5Gc-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc
Neu5Gca2-3Galb1-4Glcb
Neu5Gcalpha2-3Galbeta1-4Glcbeta
WURCS=2.0/3,3,2/[a2122h-1b_1-5][a2112h-1b_1-5][Aad21122h-2a_2-6_5*NCCO/3=O]/1-2-3/a4-b1_b3-c2

Definition

alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-D-Glcp in which the anomeric configuration of the reducing-end glucose is beta.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-D-Glcp

alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-D-Glcp Show first 5 Terms
has_role: epitope

epitope Show first 5 Terms

Phenotype

Phenotype resulting from alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp

Phenotype where environments contain alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp

Phenotype modified by environments containing alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp

Human Disease Model